175 related articles for article (PubMed ID: 23935204)
1. Faster progression to AIDS and AIDS-related death among seroincident individuals infected with recombinant HIV-1 A3/CRF02_AG compared with sub-subtype A3.
Palm AA; Esbjörnsson J; Månsson F; Kvist A; Isberg PE; Biague A; da Silva ZJ; Jansson M; Norrgren H; Medstrand P
J Infect Dis; 2014 Mar; 209(5):721-8. PubMed ID: 23935204
[TBL] [Abstract][Full Text] [Related]
2. No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in Western and West-Central Africa: a four-year prospective multicenter study.
Laurent C; Bourgeois A; Faye MA; Mougnutou R; Seydi M; Gueye M; Liégeois F; Kane CT; Butel C; Mbuagbaw J; Zekeng L; Mboup S; Mpoudi-Ngolé E; Peeters M; Delaporte E
J Infect Dis; 2002 Aug; 186(4):486-92. PubMed ID: 12195375
[TBL] [Abstract][Full Text] [Related]
3. Cocirculation of several similar but unique HIV-1 recombinant forms in Guinea-Bissau revealed by near full-length genomic sequencing.
Palm AA; Esbjörnsson J; Månsson F; Biague A; da Silva ZJ; Norrgren H; Jansson M; Medstrand P
AIDS Res Hum Retroviruses; 2015 Sep; 31(9):938-45. PubMed ID: 26066756
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from guinea-bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in West Africa.
Andersson S; Norrgren H; Dias F; Biberfeld G; Albert J
Virology; 1999 Sep; 262(2):312-20. PubMed ID: 10502510
[TBL] [Abstract][Full Text] [Related]
5. Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection.
Kiwanuka N; Laeyendecker O; Robb M; Kigozi G; Arroyo M; McCutchan F; Eller LA; Eller M; Makumbi F; Birx D; Wabwire-Mangen F; Serwadda D; Sewankambo NK; Quinn TC; Wawer M; Gray R
J Infect Dis; 2008 Mar; 197(5):707-13. PubMed ID: 18266607
[TBL] [Abstract][Full Text] [Related]
6. The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness.
Njai HF; Gali Y; Vanham G; Clybergh C; Jennes W; Vidal N; Butel C; Mpoudi-Ngolle E; Peeters M; Ariën KK
Retrovirology; 2006 Jul; 3():40. PubMed ID: 16817969
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa.
Imamichi H; Koita O; Dabitao D; Dao S; Ibrah M; Sogoba D; Dewar RL; Berg SC; Jiang MK; Parta M; Washington JA; Polis MA; Lane HC; Tounkara A
AIDS Res Hum Retroviruses; 2009 Jan; 25(1):45-55. PubMed ID: 19182920
[TBL] [Abstract][Full Text] [Related]
8. Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease--indication of an evolving epidemic in West Africa.
Esbjörnsson J; Månsson F; Martínez-Arias W; Vincic E; Biague AJ; da Silva ZJ; Fenyö EM; Norrgren H; Medstrand P
Retrovirology; 2010 Mar; 7():23. PubMed ID: 20307309
[TBL] [Abstract][Full Text] [Related]
9. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
[TBL] [Abstract][Full Text] [Related]
10. [Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the highly active antiretroviral therapy (HAART)].
Pezzotti P; Dorrucci M; Donisi A; Cusini M; Mazzarello G; De Luca A; Salassa B; Ursitti MA; Giuliani M; Rezza G;
Epidemiol Prev; 2003; 27(6):348-55. PubMed ID: 15058363
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
Tai JH; Udoji MA; Barkanic G; Byrne DW; Rebeiro PF; Byram BR; Kheshti A; Carter JD; Graves CR; Raffanti SP; Sterling TR
J Infect Dis; 2007 Oct; 196(7):1044-52. PubMed ID: 17763327
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and G.
Konings FA; Burda ST; Urbanski MM; Zhong P; Nadas A; Nyambi PN
J Med Virol; 2006 May; 78(5):523-34. PubMed ID: 16555291
[TBL] [Abstract][Full Text] [Related]
13. Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy.
Chaix ML; Seng R; Frange P; Tran L; Avettand-Fenoël V; Ghosn J; Reynes J; Yazdanpanah Y; Raffi F; Goujard C; Rouzioux C; Meyer L;
Clin Infect Dis; 2013 Mar; 56(6):880-7. PubMed ID: 23223603
[TBL] [Abstract][Full Text] [Related]
14. Lipid peroxidation and total cholesterol in HAART-naïve patients infected with circulating recombinant forms of human immunodeficiency virus type-1 in Cameroon.
Teto G; Kanmogne GD; Torimiro JN; Alemnji G; Nguemaim FN; Takou D; Nanfack A; Tazoacha A
PLoS One; 2013; 8(6):e65126. PubMed ID: 23762297
[TBL] [Abstract][Full Text] [Related]
15. [Genetic diversity of HIV infection worldwide and its consequences].
Peeters M; Delaporte E
Med Trop (Mars); 1999; 59(4 Pt 2):449-55. PubMed ID: 10901846
[TBL] [Abstract][Full Text] [Related]
16. Survival rate of AIDS disease and mortality in HIV-infected patients in Hamadan, Iran: a registry-based retrospective cohort study (1997-2011).
Mirzaei M; Poorolajal J; Khazaei S; Saatchi M
Int J STD AIDS; 2013 Nov; 24(11):859-66. PubMed ID: 23970604
[TBL] [Abstract][Full Text] [Related]
17. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
18. Characterization of HIV-1 CRF02_AG/A3/G unique recombinant forms identified among children in Larkana, Pakistan.
Rashid A; Kang L; Yi F; Mir F; Getaneh Y; Shao Y; Abidi SH
Front Cell Infect Microbiol; 2023; 13():1284815. PubMed ID: 37965253
[TBL] [Abstract][Full Text] [Related]
19. A novel multiregion hybridization assay reveals high frequency of dual inter-subtype infections among HIV-positive individuals in Cameroon, West Central Africa.
Vidal N; Diop H; Montavon C; Butel C; Bosch S; Ngole EM; Touré-Kane C; Mboup S; Delaporte E; Peeters M
Infect Genet Evol; 2013 Mar; 14():73-82. PubMed ID: 23232100
[TBL] [Abstract][Full Text] [Related]
20. Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy.
Easterbrook PJ; Smith M; Mullen J; O'Shea S; Chrystie I; de Ruiter A; Tatt ID; Geretti AM; Zuckerman M
J Int AIDS Soc; 2010 Feb; 13():4. PubMed ID: 20205896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
